By Bryan Koenig ( July 1, 2019, 9:41 PM EDT) -- Mylan urged a Kansas federal judge Friday to nix Sanofi's antitrust allegations in a broader multidistrict litigation, arguing that its EpiPen competed with Sanofi's epinephrine auto-injector fair and square, only for the latter's product to fail and Sanofi to foist the blame on Mylan....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.